Related Experiment Videos
Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care
Philippe Seguin1, Yannick Fédun, Bruno Laviolle
1Service de Réanimation Chirurgicale, Université Rennes 1, INSERM U991, Hôpital de Pontchaillou, 2 rue Henri Le Guilloux, 35033 Rennes Cedex 9, Rennes, France. philippe.seguin@chu-rennes.fr
Objectives:
This prospective non-interventional study investigated the risk factors for multidrug-resistant bacteria (MDRB) in patients with post-operative peritonitis (POP), to provide guidance for empirical antimicrobial therapy.
Methods:
All consecutive patients, >15 years old, admitted to a surgical intensive care unit (ICU) between September 2006 and January 2009 for a first episode of POP were included. Antibiotic susceptibilities of microorganisms recovered from blood cultures and peritoneal fluid were determined by disc diffusion. Amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, imipenem, gentamicin, amikacin and ciprofloxacin were tested against Gram-negative bacteria, and oxacillin, amoxicillin, vancomycin, gentamicin and erythromycin were tested against aerobic Gram-positive bacteria. Results were reported as susceptible or resistant.
Results:
MDRB were isolated from 20/115 (17%) patients. In univariate analysis, use of antimicrobial therapy during the 3 months prior to hospitalization and a long duration between hospital admission or first operation and relaparotomy were significantly associated with MDRB recovery. In multivariate analysis, only antimicrobial treatment in the 3 months preceding hospitalization and duration between first operation and relaparotomy were independent risk factors for MDRB [odds ratio (OR) = 5.80, 95% confidence interval (95% CI) = 1.99-16.91 and OR = 1.10, 95% CI = 1.02-1.19, respectively]. No MDRB were found when the delay between the first operation and relaparotomy was <5 days. POP severity, non-surgical and surgical complications, hospital and ICU length of stay, and mortality were similar in patients with and without MDRB.
Conclusions:
Our results suggest that broad-spectrum antibiotics should be used in ICU patients with POP who have received antimicrobial therapy in the 3 months prior to hospitalization, or with >5 days between the first operation and relaparotomy.
Insights
Prior antibiotic use and delayed surgery increase multidrug-resistant bacteria (MDRB) risk in post-operative peritonitis (POP) patients. Empirically broad-spectrum antibiotics are recommended for high-risk POP cases.
Area of Science:
- Infectious Diseases
- Surgical Critical Care
- Antimicrobial Resistance
Background:
- Post-operative peritonitis (POP) poses significant risks, including multidrug-resistant bacteria (MDRB) development.
- Identifying risk factors for MDRB in POP is crucial for effective empirical antimicrobial therapy.
Purpose of the Study:
- To investigate risk factors associated with MDRB in patients experiencing their first episode of POP.
- To inform empirical antimicrobial treatment strategies for POP patients.
Main Methods:
- Prospective, non-interventional study of 115 adult patients with POP in a surgical intensive care unit (ICU).
- Inclusion criteria: age >15 years, first POP episode, ICU admission between September 2006 and January 2009.
- Antibiotic susceptibility testing performed on blood and peritoneal fluid cultures using disc diffusion.
Main Results:
- MDRB were identified in 17% (20/115) of POP patients.
- Independent risk factors for MDRB included prior antimicrobial therapy (OR=5.80) and a delay >5 days between the first operation and relaparotomy (OR=1.10).
- No MDRB were detected when the delay to relaparotomy was less than 5 days.
Conclusions:
- Patients with POP who received antibiotics within 3 months prior to hospitalization are at higher risk for MDRB.
- POP patients with a delay of over 5 days between the first operation and relaparotomy also face increased MDRB risk.
- Broad-spectrum antibiotic use is recommended for ICU patients with POP exhibiting these risk factors.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test